Department of Urology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Molecular Cell Biology, Institute of Biology, Leiden University, Leiden, the Netherlands.
Cancer Res. 2015 Jun 1;75(11):2326-36. doi: 10.1158/0008-5472.CAN-14-2155. Epub 2015 Apr 9.
Altered microRNA (miRNA; miR) expression is associated with tumor formation and progression of various solid cancers. A major challenge in miRNA expression profiling of bulk tumors is represented by the heterogeneity of the subpopulations of cells that constitute the organ, as well as the tumor tissue. Here, we analyzed the expression of miRNAs in a subpopulation of epithelial stem/progenitor-like cells in human prostate cancer [prostate cancer stem cell (PCSC)] and compared their expression profile to more differentiated cancer cells. In both cell lines and clinical prostate cancer specimens, we identified that miR-25 expression in PCSCs was low/absent and steadily increased during their differentiation into cells with a luminal epithelial phenotype. Functional studies revealed that overexpression of miR-25 in prostate cancer cell lines and selected subpopulation of highly metastatic and tumorigenic cells (ALDH(high)) strongly affected the invasive cytoskeleton, causing reduced migration in vitro and metastasis via attenuation of extravasation in vivo. Here, we show, for the first time, that miR-25 can act as a tumor suppressor in highly metastatic PCSCs by direct functional interaction with the 3'-untranslated regions of proinvasive αv- and α6-integrins. Taken together, our observations suggest that miR-25 is a key regulator of invasiveness in human prostate cancer through its direct interactions with αv- and α6-integrin expression.
miRNA(miR)表达的改变与各种实体瘤的肿瘤形成和进展有关。批量肿瘤中 miRNA 表达谱分析的主要挑战是构成器官的细胞亚群以及肿瘤组织的异质性。在这里,我们分析了人前列腺癌[前列腺癌干细胞(PCSC)]中上皮干细胞/祖细胞样细胞亚群的 miRNA 表达,并将其表达谱与分化程度更高的癌细胞进行了比较。在细胞系和临床前列腺癌标本中,我们确定 PCSC 中的 miR-25 表达低/不存在,并在其分化为具有管腔上皮表型的细胞时稳定增加。功能研究表明,在前列腺癌细胞系和选择的高转移性和致瘤性细胞(ALDH(高))的亚群中过表达 miR-25 强烈影响了侵袭性细胞骨架,导致体外迁移减少,并通过体内减弱血管外渗而转移。在这里,我们首次表明,miR-25 通过与前侵袭性 αv-和 α6-整联蛋白的 3'-非翻译区的直接功能相互作用,在高转移性 PCSC 中作为肿瘤抑制因子发挥作用。总之,我们的观察结果表明,miR-25 通过与 αv-和 α6-整联蛋白表达的直接相互作用,成为人类前列腺癌侵袭性的关键调节剂。